LEP and leiomyoma: The respective inhibitors reduced the levels of pSTAT, pERK1/2, and pAKT and suppressed the intracellular staining intensity of PCNA, TNF-α, TGF-β3, and VEGF-A, in addition to reversing the effect of leptin treatment and adipocyte coculture on leiomyoma cell growth.